324 related articles for article (PubMed ID: 18627789)
21. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidic acid activates nuclear factor kappa B and induces proinflammatory gene expression in endothelial cells.
Palmetshofer A; Robson SC; Nehls V
Thromb Haemost; 1999 Nov; 82(5):1532-7. PubMed ID: 10595650
[TBL] [Abstract][Full Text] [Related]
23. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.
Xu H; Czerwinski P; Hortmann M; Sohn HY; Förstermann U; Li H
Cardiovasc Res; 2008 May; 78(2):349-55. PubMed ID: 18056764
[TBL] [Abstract][Full Text] [Related]
25. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1β expression is required for lysophosphatidic Acid-induced lymphangiogenesis in human umbilical vein endothelial cells.
Lin CH; Lu J; Lee H
Int J Inflam; 2010 Aug; 2011():351010. PubMed ID: 21151531
[TBL] [Abstract][Full Text] [Related]
27. Shikonin Suppresses Lymphangiogenesis via NF-κB/HIF-1α Axis Inhibition.
Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Svasti J; Koizumi K
Biol Pharm Bull; 2018; 41(11):1659-1666. PubMed ID: 30381665
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells.
Khoi PN; Li S; Thuan UT; Sah DK; Kang TW; Nguyen TT; Lian S; Xia Y; Jung YD
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906413
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro.
Okuyama K; Mizuno K; Nittami K; Sakaue H; Sato T
Microvasc Res; 2022 Jan; 139():104273. PubMed ID: 34699844
[TBL] [Abstract][Full Text] [Related]
31. Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.
Sun J; Lin X
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17085-90. PubMed ID: 18952848
[TBL] [Abstract][Full Text] [Related]
32. Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism.
Lin CI; Chen CN; Chen JH; Lee H
J Cell Biochem; 2006 Nov; 99(4):1216-32. PubMed ID: 16795034
[TBL] [Abstract][Full Text] [Related]
33. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
34. Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65.
Shimada H; Rajagopalan LE
J Biol Chem; 2010 Apr; 285(17):12536-42. PubMed ID: 20164172
[TBL] [Abstract][Full Text] [Related]
35. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells.
Mu H; Ohashi R; Yan S; Chai H; Yang H; Lin P; Yao Q; Chen C
Cardiovasc Res; 2006 Apr; 70(1):146-57. PubMed ID: 16515776
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of endothelial cell migration by constitutively active LPA(1)-expressing tumor cells.
Kitayoshi M; Kato K; Tanabe E; Yoshikawa K; Fukui R; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2012 Jun; 422(2):339-43. PubMed ID: 22580000
[TBL] [Abstract][Full Text] [Related]
37. High-mobility group box 1 protein activating nuclear factor-κB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
Li Y; He J; Zhong D; Li J; Liang H
J Int Med Res; 2015 Aug; 43(4):494-505. PubMed ID: 26001393
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.
Shida D; Kitayama J; Yamaguchi H; Yamashita H; Mori K; Watanabe T; Nagawa H
World J Gastroenterol; 2005 Sep; 11(36):5638-43. PubMed ID: 16237757
[TBL] [Abstract][Full Text] [Related]
39. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.
Ren B; Hale J; Srikanthan S; Silverstein RL
Blood; 2011 Jun; 117(22):6036-45. PubMed ID: 21441463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
